AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PCVX
2. PTC
3. NVDA
4. SPY
5. META
6. MSFT
7. GMAB
8. BETR
9. BBIO
10. USO

Go back to AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS

Amgen (AMGN) Reports Q4 Beat

February 7, 2022 4:59 PM EST

Amgen (NASDAQ: AMGN) reported its Q4 results, with EPS coming in at $4.36, beating the consensus estimate of $4.12. Revenue grew 3% year-over-year to $6.85 billion, slightly missing the consensus estimate of $6.88 billion, driven by increased Other Revenue from the Eli Lilly and Company COVID-19 manufacturing collaboration.

Total... More

Amgen (AMGN) Tops Q4 EPS by 24c

February 7, 2022 4:02 PM EST

Amgen (NASDAQ: AMGN) reported Q4 EPS of $4.36, $0.24 better than the analyst estimate of $4.12. Revenue for the quarter came in at $6.85 billion versus the consensus estimate of $6.88 billion.

For earnings history and earnings-related data on Amgen (AMGN) click here.

... More